| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PEDIATRICS Vol. 106 No. 6 December 2000, pp. 1500-1504
AMERICAN ACADEMY OF PEDIATRICS:
Meningococcal Disease Prevention and Control Strategies for
Practice-Based Physicians (Addendum: Recommendations for College
Students)
The numbers of reported cases of meningococcal disease in 15- to 24-year-olds and outbreaks of meningococcal serogroup C disease, including outbreaks in schools and other institutions, have increased during the past decade. In response to outbreaks on college campuses, the American College Health Association has taken an increasingly proactive role in alerting college students and their parents to the risk of this disease and informing them about the availability of an effective vaccine. Recent epidemiologic studies have demonstrated an increased risk of disease in college students living in dormitories, particularly among freshmen, compared with similarly aged persons in the general population. At least 60% of these cases are potentially preventable by vaccination with the quadrivalent meningococcal A, C, Y, and W-135 polysaccharide vaccine. These findings support immunization of college students, particularly freshmen living in dormitories. Hence, college students and their parents should be informed by health care professionals at routine prematriculation visits and during college matriculation of the risk of meningococcal disease and potential benefits of immunization. Vaccine should be made available to those requesting immunization. College and university health services also should facilitate implementation of educational programs concerning meningococcal disease and availability of immunization services.
.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
The following policy statement is a revision:
- Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients
Pediatrics 116: 496-505.[Full Text]
This article has been cited by other articles:
|
|
 |
|
  Committee on Infectious Diseases Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients Pediatrics, August 1, 2005; 116(2): 496 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Way, P. A. Offit, and G. Peter Choices about Meningococcal Vaccination N. Engl. J. Med., March 11, 2004; 350(11): 1156 - 1156. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Offit and G. Peter The Meningococcal Vaccine -- Public Policy and Individual Choices N. Engl. J. Med., December 11, 2003; 349(24): 2353 - 2356. [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Dennehy Active Immunization in the United States: Developments over the Past Decade Clin. Microbiol. Rev., October 1, 2001; 14(4): 872 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Bruce, N. E. Rosenstein, J. M. Capparella, K. A. Shutt, B. A. Perkins, and M. Collins Risk Factors for Meningococcal Disease in College Students JAMA, August 8, 2001; 286(6): 688 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Harrison, M. A. Pass, A. B. Mendelsohn, M. Egri, N. E. Rosenstein, A. Bustamante, J. Razeq, and J. C. Roche Invasive Meningococcal Disease in Adolescents and Young Adults JAMA, August 8, 2001; 286(6): 694 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Rosenstein, B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes Meningococcal Disease N. Engl. J. Med., May 3, 2001; 344(18): 1378 - 1388. [Full Text] [PDF]
|
|
|
|
 |
|
 L. O'Keefe AAP addresses meningococcal disease risk in college freshmen AAP News, December 1, 2000; 17(6): 253 - 253. [Full Text] [PDF]
|
|
